A phase II study of paclitaxel plus carb
✍
Edith A. Perez; David W. Hillman; Philip J. Stella; James E. Krook; Lynn C. Hart
📂
Article
📅
2000
🏛
John Wiley and Sons
🌐
English
⚖ 96 KB
👁 3 views
## BACKGROUND. This Phase II multicenter study evaluated the efficacy and toxicity of paclitaxel (200 mg/m 2 by 3-hour infusion) with carboplatin (area under the curve 6 mg/mL per minute) administered every 3 weeks as first-line therapy for women with metastatic breast carcinoma. ## METHODS. Eligi